Definitive Healthcare Is Maintained at Neutral by Goldman Sachs
Goldman Sachs Maintains Definitive Healthcare(DH.US) With Hold Rating, Cuts Target Price to $3
Definitive Healthcare Is Maintained at Underweight by Barclays
Definitive Healthcare Analyst Ratings
Barclays Maintains Definitive Healthcare(DH.US) With Sell Rating, Cuts Target Price to $3
A Quick Look at Today's Ratings for Definitive Healthcare(DH.US), With a Forecast Between $5 to $7
A Quick Look at Today's Ratings for Definitive Healthcare(DH.US), With a Forecast Between $5 to $7
Definitive Healthcare Corp: Hold Rating Amid Retention Challenges and Strategic Opportunities
William Blair Remains a Buy on Definitive Healthcare Corp (DH)
Needham Maintains Definitive Healthcare(DH.US) With Hold Rating
Needham Sticks to Its Hold Rating for Definitive Healthcare Corp (DH)
Barclays Downgrades Definitive Healthcare(DH.US) to Sell Rating, Maintains Target Price $4
Stephens Initiates Definitive Healthcare(DH.US) With Hold Rating, Announces Target Price $5
Definitive Healthcare Analyst Ratings
BTIG Maintains Definitive Healthcare(DH.US) With Buy Rating, Maintains Target Price $7
A Quick Look at Today's Ratings for Definitive Healthcare(DH.US), With a Forecast Between $5 to $6
Needham Maintains Definitive Healthcare(DH.US) With Hold Rating
Needham Reaffirms Their Hold Rating on Definitive Healthcare Corp (DH)
Definitive Healthcare Analyst Ratings
BTIG Initiates Definitive Healthcare(DH.US) With Buy Rating, Announces Target Price $7